Manulife (Manufacturers Life Insurance)’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,039
| Closed | -$73.9K | – | 2909 |
|
|
2025
Q3 | $73.9K | Sell |
10,039
-815
| -8% | -$6.17K | ﹤0.01% | 2832 |
|
|
2025
Q2 | $88.1K | Buy |
+10,854
| New | +$73.2K | ﹤0.01% | 2784 |
|
|
2023
Q2 | – | Sell |
-11,561
| Closed | -$43.6K | – | 3018 |
|
|
2023
Q1 | $43.6K | Hold |
11,561
| – | – | ﹤0.01% | 2881 |
|
|
2022
Q4 | $74.9K | Sell |
11,561
-115
| -1% | -$948 | ﹤0.01% | 2859 |
|
|
2022
Q3 | $104K | Hold |
11,676
| – | – | ﹤0.01% | 2802 |
|
|
2022
Q2 | $116K | Sell |
11,676
-673
| -5% | -$6.66K | ﹤0.01% | 2858 |
|
|
2022
Q1 | $143K | Sell |
12,349
-4,464
| -27% | -$49.7K | ﹤0.01% | 2887 |
|
|
2021
Q4 | $187 | Sell |
16,813
-1,452
| -8% | -$14.1K | ﹤0.01% | 2915 |
|
|
2021
Q3 | $168K | Sell |
18,265
-925
| -5% | -$10.1K | ﹤0.01% | 3037 |
|
|
2021
Q2 | $216K | Buy |
19,190
+221
| +1% | +$2.55K | ﹤0.01% | 3054 |
|
|
2021
Q1 | $201K | Buy |
18,969
+1,516
| +9% | +$17K | ﹤0.01% | 2890 |
|
|
2020
Q4 | $189K | Buy |
17,453
+525
| +3% | +$5.42K | ﹤0.01% | 2800 |
|
|
2020
Q3 | $165K | Hold |
16,928
| – | – | ﹤0.01% | 2647 |
|
|
2020
Q2 | $166K | Sell |
16,928
-376
| -2% | -$3.88K | ﹤0.01% | 2578 |
|
|
2020
Q1 | $150K | Buy |
17,304
+1,216
| +8% | +$12.7K | ﹤0.01% | 2446 |
|
|
2019
Q4 | $182K | Sell |
16,088
-1,288
| -7% | -$13.7K | ﹤0.01% | 2624 |
|
|
2019
Q3 | $185K | Sell |
17,376
-223
| -1% | -$2.43K | ﹤0.01% | 2634 |
|
|
2019
Q2 | $165K | Buy |
+17,599
| New | +$178K | ﹤0.01% | 2746 |
|
|
2018
Q4 | – | Sell |
-11,112
| Closed | -$160K | – | 2693 |
|
|
2018
Q3 | $160K | Sell |
11,112
-9,771
| -47% | -$135K | ﹤0.01% | 2820 |
|
|
2018
Q2 | $311K | Sell |
20,883
-435
| -2% | -$6.04K | ﹤0.01% | 2754 |
|
|
2018
Q1 | $279K | Sell |
21,318
-313
| -1% | -$4.11K | ﹤0.01% | 2765 |
|
|
2017
Q4 | $272K | Sell |
21,631
-395
| -2% | -$4.99K | ﹤0.01% | 2778 |
|
|
2017
Q3 | $285K | Sell |
22,026
-662
| -3% | -$8.73K | ﹤0.01% | 2697 |
|
|
2017
Q2 | $336K | Buy |
22,688
+110
| +0.5% | +$1.53K | ﹤0.01% | 2598 |
|
|
2017
Q1 | $272K | Buy |
22,578
+3,156
| +16% | +$40K | ﹤0.01% | 2620 |
|
|
2016
Q4 | $268K | Sell |
19,422
-443
| -2% | -$6.14K | ﹤0.01% | 2563 |
|
|
2016
Q3 | $267K | Sell |
19,865
-450
| -2% | -$5.45K | ﹤0.01% | 2557 |
|
|
2016
Q2 | $219K | Buy |
20,315
+1,639
| +9% | +$18.1K | ﹤0.01% | 2645 |
|
|
2016
Q1 | $200K | Sell |
18,676
-332
| -2% | -$3.65K | ﹤0.01% | 2603 |
|
|
2015
Q4 | $225 | Buy |
19,008
+586
| +3% | +$7.2K | ﹤0.01% | 2569 |
|
|
2015
Q3 | $215 | Hold |
18,422
| – | – | ﹤0.01% | 2590 |
|
|
2015
Q2 | $265 | Buy |
18,422
+35
| +0.2% | +$505 | ﹤0.01% | 2623 |
|
|
2015
Q1 | $256 | Buy |
18,387
+598
| +3% | +$8.26K | ﹤0.01% | 2547 |
|
|
2014
Q4 | $245 | Sell |
17,789
-805
| -4% | -$10.4K | ﹤0.01% | 2499 |
|
|
2014
Q3 | $228 | Sell |
18,594
-47
| -0.3% | -$587 | ﹤0.01% | 2554 |
|
|
2014
Q2 | $233K | Sell |
18,641
-2,988
| -14% | -$35.2K | ﹤0.01% | 2607 |
|
|
2014
Q1 | $242 | Hold |
21,629
| – | – | ﹤0.01% | 2584 |
|
|
2013
Q4 | $262 | Buy |
21,629
+2,128
| +11% | +$25.4K | ﹤0.01% | 2518 |
|
|
2013
Q3 | $238 | Sell |
19,501
-210
| -1% | -$2.93K | ﹤0.01% | 2520 |
|
|
2013
Q2 | $261K | Buy |
+19,711
| New | +$273K | ﹤0.01% | 2359 |
|
Other funds holding LFCR
WC
LPAM
GRIM
2L
3C
GC
Manulife (Manufacturers Life Insurance)'s LFCR Position: Q4 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of Lifecore Biomedical (LFCR) in Q4 2025, closing a stake of 10,039 shares — an estimated $73.9K sold.
Manulife (Manufacturers Life Insurance) first reported a position in LFCR in Q2 2013 and held it in 40 quarters. The position peaked at $336K in Q2 2017. 103 funds tracked by Wall St. Rank hold LFCR as of Q4 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining Lifecore Biomedical position as of Q4 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 10,039 Lifecore Biomedical shares in Q4 2025, an estimated $73.9K.
- Manulife (Manufacturers Life Insurance) first reported a position in Lifecore Biomedical in Q2 2013 and held it in 40 quarters.
- Manulife (Manufacturers Life Insurance)'s Lifecore Biomedical position peaked at $336K in Q2 2017.
- 103 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2025, filed 13 Feb 2026.